Yayınlar & Eserler

Yayın Ağı
Makaleler 4
Tümü (4)
SCI-E, SSCI, AHCI (4)
SCI-E, SSCI, AHCI, ESCI (4)
Scopus (4)
TRDizin (1)

1. Biological evaluation of novel 6,9-disubstituted purine analogues in high-grade serous ovarian cancer cell lines

Altiparmak D., Demirel Yavuz D., KUL KARADENİZLİ P., Durmaz Şahin İ., TUNÇBİLEK M.
Turkish Journal of Biology , cilt.50, sa.1, ss.29-36, 2026 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

2. Synthesis and cytotoxicity of novel 6,8,9-trisubstituted purine analogs against liver cancer cells

POLAT M. F., Durmaz Şahin I., KUL P., Cetin Atalay R., TUNÇBİLEK M.
Bioorganic and Medicinal Chemistry Letters , cilt.106, 2024 (SCI-Expanded, Scopus) identifier identifier

3. Incorporation of Protecting Groups in Organic Chemistry: A Mini-Review

Kışla M. M., Hassan M. A., Osman H. M., Aydın A. S., Sen H. T., Khazei S., et al.
CURRENT ORGANIC SYNTHESIS , cilt.20, sa.5, ss.491-503, 2023 (SCI-Expanded, Scopus) identifier

4. A Novel 6,8,9-Trisubstituted Purine Analogue Drives Breast Cancer Luminal A Subtype MCF-7 to Apoptosis and Senescence through Hsp70 Inhibition

KUL P., TUNÇBİLEK M., ERGÜL M., Tunoglu E. N. Y., Tutar Y.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , cilt.23, sa.5, ss.585-598, 2023 (SCI-Expanded, Scopus) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 2

1. MOLNUPIRAVIR: A NEW ANTIVIRAL DRUG FOR COVID-19 TREATMENT

KUL P., TUNÇBİLEK M.
2. INTERNATIONAL MARMARA SCIENTIFIC RESEARCH AND INNOVATION CONGRESS, İstanbul, Türkiye, 19 Nisan 2022, ss.63, (Özet Bildiri)

2. DESIGN SYNTHESIS AND IN VITRO BIOLOGICAL ACTIVITIES OF NEW 6,8,9-TRISUBSTITUTED PURINE DERIVATIVES AS PROMISING HSPs INHIBITORS

KUL P., TUNÇBİLEK M., ERGÜL M., Yenilmez Tunoğlu E., TUTAR Y.
ISOPS-13, Ankara, Türkiye, 22 Haziran 2021, ss.65-66, (Tam Metin Bildiri)
Metrikler

Yayın

7

Yayın (WoS)

4

Yayın (Scopus)

4

Atıf (WoS)

1

H-İndeks (WoS)

1

Proje

1